English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To investigate the susceptibility of heterozygous p53-deficient CBA mice [p53 (+/-) mice] to promotion of liver proliferative lesions in a two stage hepatocarcinogenesis model, 30 p53 (+/-) mice and 30 wild-type littermates [p53 (+/+) mice] received an i.p injection of 5 mg/kg of N-nitrosodimethylamine (DMN), and from one week later, each group was given free access to drinking water containing 0.05 or 0 % of phenobarbital (PB) for 26 weeks. The final body weights were significantly decreased in both p53 (+/-) and p53 (+/+) mice of the DMN+PB compared to the DMN alone groups and the liver weights were significantly increased. The survival rate was 67 and 73% in p53 (+/-) and p53 (+/ +) mice of the DMN+PB group, respectively, and there were no deaths in any of the mice receiving DMN alone. The incidences of eosinophilic foci in the liver (90 and 54.6% in p53 (+/-) and p53 (+/+) mice, respectively) in the DMN+PB groups were significantly higher than those with DMN alone (6.7% in p53 (+/-) mice, 0% in p53 (+/+) mice). The incidences of clear cell foci and hepatocellular adenomas were 10.0 and 9.1%, and 60.0 and 27.3%, respectively, in p53 (+/-) and p53 (+/+) mice receiving DMN+PB. These lesions were not seen in the DMN alone group. The PCNA labeling indices for eosinophilic foci and hepatocellular adenomas in the DMN+PB group were significantly higher in p53 (+/-) than in p53 (+/+) mice. The present results suggest that p53 (+/-) CBA mice are very susceptible to promotion of the development of liver proliferative lesions by PB after DMN initiation. (J Toxicol Pathol 2001; 14: 273278)

journal of toxicologic pathology

Susceptibility of Heterozygous p53 Deficient CBA Mice to Induction of Liver Proliferative Lesions by Phenobarbital after Dimethylnitrosamine Initiation.